2-Bromo-4-fluoro-6-(trifluoromethyl)aniline, 97.0%, 100g

(S)-2-(2-((tert-Butoxycarbonyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanamido)-2-methylpropanoic acid, 97%, 5g

Analytical and precision scale Pioneer® series Models with internal adjustment, not certified, 0.001 g, 320 g, PX323 (W)

anti-Keratin Type II mouse monoclonal, Ks pan1-8, 0.2 ml

3-ACETYL-4-HYDROXY-BENZOIC ACID, 97.0%, 25g

Methyl 3-bromo-4,5-dichlorobenzoate, 95.0%, 1g

1,6-DIBROMOISOQUINOLINE, 95%, 250mg

6-Bromo-1,3-dihydroisobenzofuran-4-amine, 100mg

Ethyl 2-(methylsulfonyl)pyrimidine-5-carboxylate, 95.0%, 1g

1-(2-(Trifluoromethyl)phenyl)ethanamine hydrochloride, 95.0%, 100mg

2-Hydroxy-3,4-dimethyl-benzaldehyde, 95%, 250mg

2-(2-Methyl-1,3-dioxolan-2-yl)acetic acid, 97%, 5g

Diltiazem.HCl, 99.5%, 25g